Drug-Resistant TB

Xiao, Heping; Tang, Shenjie; Wang, Sha; Zhang, Qing; Zhao, Jian

doi:10.1007/978-1-4939-6667-7_10

Cited by 1 publication

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…DOTS strategy is a combination of active case detection, the use of DOTS by dedicated health workers, government commitment, guaranteed supply chain for anti-TB drugs, and efficient recording and reporting systems. The objective of DOTS is to cure the patient, interrupt the chain of TB transmission to others, and prevent development of DR-TB strains [3][4]. These have been difficult to achieve as a result of several barriers mitigating against the patient and health systems thus resulting in drop-outs while TB patients are receiving a standardized anti-TB regimen.…”

Section: Introduction and Objectivesmentioning

confidence: 99%

“…Lost to follow-Up (LTFU) is a major barrier to TB control efforts and constitute an economic burden. It is also a significant cause of increased transmission of drug-resistant strains, mortality and TB reactivation [3]. Also, LTFU was a major reason for failed TB treatment, DRTB, relapse and future retreatment after completing treatment [5].…”

Section: Introduction and Objectivesmentioning

confidence: 99%

See 1 more Smart Citation

Timing and reasons for lost to follow-up among patients on 6-month standardized anti-TB treatment in Nigeria

Adepoju¹,

Adelekan²,

Adejumo³

2022

J Pre Clin Clin Res.

View full text Add to dashboard Cite

Introduction andObjective. Loss to follow-up (LTFU) along the TB care cascade is a barrier to TB control because of sustained TB transmission including resistant strains, high mortality and increased spread of DRTB strains. Understanding common reasons for LTFU and their timing could help target interventions to improve adherence to TB treatment. Materials and method. A cross-sectional study using pre-tested questionnaires were administered by phone interviews to 90 TB patients receiving treatment between January -December 2020 who were LTFU while on TB treatment in 31 health facilities across three States in South West Nigeria. The focus of the interviews was to determine the reasons why they were LTFU. Interviewers contacted treatment supporters when patients could not be reached. Clinical and socio-demographic information, such as age, sex and HIV status were extracted from treatment registers Results. The mean age of patients was 42.6 years (16-90) and SD=17.2. The majority 73 (81%) of LTFU were male, while Ogun State had the highest number -35 (38.9%), LTFU was highest during the first month on treatment -60 (66.7%), among HIV negative -63 (70%), and those who had not been treated previously for TB -85 (94.4%). The most common reason for LTFU among TB patients on treatment was death -23(25.6%), followed by lack of transport -16 (17.8%), and religious beliefs -12 (13.3%). Conclusions. The study suggests a high mortality among patients receiving treatment who may have been classified as LTFU. Interventions to reduce mortality and increase coverage of TB treatment facilities, thus bringing care closer to patients, is necessary. It is suggested that 30-day adherence calendars should be used to improve adherence counselling in the first one month on treatment to minimize early LTFU among TB patients.

show abstract

Section: Introduction and Objectivesmentioning

confidence: 99%

Section: Introduction and Objectivesmentioning

confidence: 99%